FIT vs gFOBTs: What’s changed? 

Latest from the Blog

Related Posts

Discussing impotence with patients

Discussing impotence with patients

Friday 19th June 2020 For many patients, the relief of surviving their treatment or managing their condition can be followed with questions about other aspects of their life. Impotence can be very common after treatment for colorectal cancer; often affecting up to 90%...

read more

Friday 18th October 2019

The new Faecal Immunochemical Test (FIT) rolled out across England this year has a number of benefits in replacing the use of older guaiac-based faecal occult blood tests (gFOBTs). Is your practice up to date with the new processes associated with FIT and are you aware of the reasons for the change?

Our latest course on Faecal Immunochemical Testing (FIT) is now available, outlining the use of FIT as a screening tool and appropriate use for symptomatic patients. It also includes some of the key benefits of changing to this method from gFOBTs, including:

  • Increased reliability as an indicator of abnormal pathology
  • The need for one patient sample only, compared to the previous three
  • Using antibodies that specifically recognise human haemoglobin
  • Reducing the number of repeat tests, as there are no borderline results (only normal or abnormal)

Find out more:

Find out more: visit the GatewayC Faecal Immunochemical Test course here. 1 CPD credit is available upon completion of this course.

Keep up to date: Twitter | Facebook | LinkedIn